Note 8 - Segment Information and Dissaggregated Revenue

9 Months Ended

Mar. 31, 2019

Segment Reporting Disclosure [Text Block]

Note

Segment Information

and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

March 31, 2019

and

2018

were

$1,878

and

$891,

respectively, and for the

nine

months ended

March 31, 2019

and

2018

were

$4,391

and

$3,797,

respectively.

Financial information relating to the

three

months ended

March 31, 2019

and

2018

operations by business segment and disaggregated revenues are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	11,913	$	1,875	$	13,788	$	1,995		$	68	$	63
	2018		9,333		879		10,212		1,363			55		42
Branded Proprietary Products	2019		14		3		17		7			-		-
	2018		-		9		9		(2	)		1		-
Other Nutraceutical Businesses	2019		283		-		283		92			1		-
	2018		351		3		354		108			1		-
Total Company	2019		12,210		1,878		14,088		2,093			69		63
	2018		9,684		891		10,575		1,469			57		42

Financial information relating to the

nine

months ended

March 31, 2019

and

2018

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2019	$	31,066	$	4,330	$	35,396	$	4,323	$	199	$	350
	2018		26,314		3,661		29,975		3,094		184		244
Branded Proprietary Products	2019		133		22		155		49		-		-
	2018		181		30		211		95		3		13
Other Nutraceutical Businesses	2019		803		39		842		271		2		-
	2018		853		106		959		333		2		1
Total Company	2019		32,002		4,391		36,393		4,643		201		350
	2018		27,348		3,797		31,145		3,522		189		258

	Total Assets as of
	March 31,		June 30,
	2019		2018
Contract Manufacturing	$	19,756	$	12,200

Branded Proprietary Products		585		543

Other Nutraceutical Businesses		1,880		1,825
Total Company	$	22,221	$	14,568